en   |   pl
1030 responses worldwide

responses

All categories Health Inclusion Lockdown Unemployment
All types Response Response Expanded Solution

Found entries: 21

× Reset filters
Health,
Published 27.06.2020 13:18
In Brazil, a public science and technology organization creates a data repository to help Covid-19 research.
FAPESP, an institution in São Paulo that is one of the main agencies for the promotion of scientific and technological research in the country, launched Data Sharing BR with demographic data and clinical and laboratory exams of patients tested for Covid-19 in the state of São Paulo. The data is…
Health,
Published 24.06.2020 15:15
UK researchers are to test whether an experimental drug can prevent potentially deadly blood clots associated with Covid-19.
A new drug for preventing lung damage and blood clots in people with coronavirus is set to be trialled in UK hospitals with support from researchers at the British Heart Foundation of Research Excellence at Imperial College London. The drug, TRV027, works to restore the balance and could dampen the…
Health, Lockdown,
Published 24.06.2020 10:55
Two studies published by scientists concluded that millions of lives have been saved thanks to large-scale interventions during the pandemic.
According to the Imperial study, European lockdowns helped to prevent more than 3.1 million deaths. The Berkeley study, which examined infection rates and lockdown measures in China, South Korea, Italy, Iran, France, and the US, found that local and national interventions prevented more than 530 million cases. Both of these…
Health, , , , ,
Published 24.06.2020 14:55
Germany, France, Italy, and the Netherlands have signed a contract for pre-orders of 300 million doses of a coronavirus vaccine currently in development.
The deal was signed with pharmaceutical company AstraZeneca for a promising coronavirus vaccine currently still in the experimental phase. All EU countries will be able to take part in the program. The vaccine is expected to be finished by the end of 2020.
Health,
Published 23.06.2020 17:51
A German biotech company is using yeast to create a vaccine that would bring a permanent end to the coronavirus pandemic.
Based in Langenfeld in the German state of North Rhine-Westphalia, ARTES Biotechnology has already used yeast cells to bring a hepatitis B vaccine to market. Yeast, they believe, will help produce proteins that could be used to trigger the production of coronavirus antibodies in humans.
Health, ,
Published 13.06.2020 12:21
In Zambia scientists are using new technology to track Covid-19.
Scientists from PATH are using on-site genetic sequencing with nanopore technology which can allow them to read complex strings of RNA or DNA without a complex laboratory setting to track Covid-19. Through this technology, they are able to track Covid-19 and mutations that may occur as the virus replicates. The…
Health,
Published 13.06.2020 11:20
In the UK, more than 31,000 close contacts of people with coronavirus were identified during the first week of the test and trace system.
Nearly 27,000 contacted within 24 hours and asked to self-isolate. The success of the programme is critical to the country’s ability to combat the spread of Covid-19 and prevent a second spike as the nation moves gradually out of lockdown. UK Health Secretary Matt Hancock said people had a “civic…
Health,
Published 20.06.2020 14:50
Israeli researchers have developed a prototype face mask which can clean itself using electricity provided by a phone charger.
Scientists from the Technion Faculty of Materials Science and Engineering in Haifa say the electricity will heat up a carbon fibre layer and kill off any viruses that have settled on it. They have already filed a patent application for the mask with the aim of making it commercially available…
Health,
Published 29.06.2020 09:01
Scientists from Stanford University develop a gene-editing tool that can destroy Covid-19 inside human cells.
The Stanford team partnered up with researchers at the Department of Energy’s Lawrence Berkeley National Laboratory to develop a technique called prophylactic antiviral CRISPR in human cells, or PAC-MAN. By scrambling the virus’s genetic code, PAC-MAN could neutralise the coronavirus and stop it from replicating inside cells.
Health,
Published 18.06.2020 12:16
In Poland, a biotechnological company Scope Fluidics developed a fast test that detects Covid-19.
It has completed the “proof-of-concept” stage of development of the diagnostic panel that enables detection of the coronavirus. Now, the company is going to optimise, analyse and validate the test, and complete the work on the panel. Scope Fluidics was established in 2010 in the Institute of Physical Chemistry of…

Thank you for submitting!

Our reporters will get back to you shortly!

submit a response

Do you know about any initiative, action, project, law…  anything which tries to solve effect of COVID-19? Let us know!

The initiatives can be responses to different effects: unemployment or economic consequences, inclusion of the most vulnerable populations, health responses. And more.
Country, city or area
If you have any source link to it!
We will inform you once your response gets verified and send a lot of love!

 

 

 

en pl
Subscribe

We use cookies on our website. Some materials published on our website include third party content, that use cookies on the behalf of other websites. These websites are Twitter, Facebook, Youtube and Instagram. If you do not agree for the use of cookies by us and by those websites, disable the cookies option in the browser or on the device You are using. If you use the opt-out option, you will not have access to our contents. You can find out more about the data processing in the “Privacy policy” page.

Ok